Physician profile
Carlo G Garibaldi
NPI 1083745178
$6,983.79
in general payments reported to CMS, 2019-2025
17 companies · $5,592 in 2025
The $5,592 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2021: $61.74 · 2022: $111 · 2023: $84.47 · 2024: $153 · 2025: $5,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,824 · Education: $2,500 · Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,824.29 |
| Education | $2,500.00 |
| Food and Beverage | $504.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,039.45 | 2019-2025 | |
| Applied Medical Resources Corporation | $183.01 | 2024-2025 | Gelpoint V-Path |
| Avanos Medical | $148.37 | 2019 | |
| Organon LLC | $131.17 | 2021-2023 | Nexplanon |
| Caris Mpi, INC. | $122.69 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $50.27 | 2019-2023 | Gardasil 9 |
| Hologic Sales and Service, LLC | $42.21 | 2021-2025 | Acessa Provu System |
| Pfizer INC. | $38.78 | 2023-2024 | |
| Ethicon US, LLC | $37.14 | 2024 | Stratafix, Dermabond Prineo |
| Viiv Healthcare Company | $34.55 | 2024 | Cabenuva |
| Sanofi Pasteur INC. | $31.71 | 2023 | |
| Alexion Pharmaceuticals, INC. | $30.63 | 2024 | Ultomiris |
| Biogen, INC. | $27.98 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $18.40 | 2025 | Gemtesa |
| Amag Pharmaceuticals, INC. | $18.07 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $15.72 | 2021 | |
| Therapeuticsmd, INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlo Garibaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.